| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected and Quantified |
|---|
| Creation Date | 2007-04-12 17:05:12 UTC |
|---|
| Update Date | 2021-09-14 15:47:52 UTC |
|---|
| HMDB ID | HMDB0005897 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Dihydrogenistein |
|---|
| Description | Dihydrogenistein is a metabolite of the soy isoflavone genistin (the glycoside conjugate of genistein) by intestinal bacteria. Isoflavones are one of the three major classes of phytoestrogens; phytoestrogens are a diverse group of plant-derived compounds that structurally and functionally mimic mammalian estrogen. The isoflavone genistin is one of the most prevalent in soy foods. They are biologically inactive; once ingested, they are cleaved by glucosidases to "aglycones", genistein. Epidemiological studies have associated high soy intake with a lowered risk for certain hormone-dependent disease. Many studies reveal that the incidence of prostate cancer and breast cancer is much lower in Asian people in comparison to people from the West and, and the prevailing contribution to this difference has been attributed to the diet. Soy foods and soy-derived products which contain abundant isoflavones are consumed in large quantities by Asian people. In vitro, isoflavone metabolites have dual functions: they can act as an estrogenic agonist or antagonist depending on the estrogen concentration. (PMID: 17499260 , 16965913 ). Dihydrogenistein is a biomarker for the consumption of soy beans and other soy products. |
|---|
| Structure | OC1=CC=C(C=C1)C1COC2=CC(O)=CC(O)=C2C1=O InChI=1S/C15H12O5/c16-9-3-1-8(2-4-9)11-7-20-13-6-10(17)5-12(18)14(13)15(11)19/h1-6,11,16-18H,7H2 |
|---|
| Synonyms | | Value | Source |
|---|
| 2,3-Dihydro-5,7-dihydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one | ChEBI | | 4',5,7-Trihydroxyisoflavan-4-one | ChEBI | | 4',5,7-Trihydroxyisoflavanone | ChEBI | | 4',5,7-Trihydroxy-isoflavanone | HMDB |
|
|---|
| Chemical Formula | C15H12O5 |
|---|
| Average Molecular Weight | 272.2528 |
|---|
| Monoisotopic Molecular Weight | 272.068473494 |
|---|
| IUPAC Name | 5,7-dihydroxy-3-(4-hydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-4-one |
|---|
| Traditional Name | dihydrogenistein |
|---|
| CAS Registry Number | 21554-71-2 |
|---|
| SMILES | OC1=CC=C(C=C1)C1COC2=CC(O)=CC(O)=C2C1=O |
|---|
| InChI Identifier | InChI=1S/C15H12O5/c16-9-3-1-8(2-4-9)11-7-20-13-6-10(17)5-12(18)14(13)15(11)19/h1-6,11,16-18H,7H2 |
|---|
| InChI Key | UQGVUYNHDKMLSE-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as isoflavanones. These are polycyclic compounds containing an isoflavan skeleton which bears a ketone at position C4. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Phenylpropanoids and polyketides |
|---|
| Class | Isoflavonoids |
|---|
| Sub Class | Isoflavans |
|---|
| Direct Parent | Isoflavanones |
|---|
| Alternative Parents | |
|---|
| Substituents | - Isoflavanone
- Isoflavanol
- Hydroxyisoflavonoid
- Chromone
- 1-benzopyran
- Benzopyran
- Chromane
- Aryl alkyl ketone
- Aryl ketone
- Alkyl aryl ether
- 1-hydroxy-4-unsubstituted benzenoid
- Phenol
- 1-hydroxy-2-unsubstituted benzenoid
- Benzenoid
- Monocyclic benzene moiety
- Vinylogous acid
- Ketone
- Oxacycle
- Organoheterocyclic compound
- Ether
- Organic oxygen compound
- Hydrocarbon derivative
- Organic oxide
- Organooxygen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 6.28 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 11.7904 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.42 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 26.4 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1930.1 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 280.6 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 127.9 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 167.7 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 212.5 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 574.0 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 503.8 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 107.1 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 945.1 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 400.7 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1350.1 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 342.8 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 353.5 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 475.6 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 176.6 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 195.6 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Dihydrogenistein,1TMS,isomer #1 | C[Si](C)(C)OC1=CC=C(C2COC3=CC(O)=CC(O)=C3C2=O)C=C1 | 2823.6 | Semi standard non polar | 33892256 | | Dihydrogenistein,1TMS,isomer #2 | C[Si](C)(C)OC1=CC(O)=C2C(=O)C(C3=CC=C(O)C=C3)COC2=C1 | 2785.3 | Semi standard non polar | 33892256 | | Dihydrogenistein,1TMS,isomer #3 | C[Si](C)(C)OC1=CC(O)=CC2=C1C(=O)C(C1=CC=C(O)C=C1)CO2 | 2813.6 | Semi standard non polar | 33892256 | | Dihydrogenistein,2TMS,isomer #1 | C[Si](C)(C)OC1=CC=C(C2COC3=CC(O[Si](C)(C)C)=CC(O)=C3C2=O)C=C1 | 2779.1 | Semi standard non polar | 33892256 | | Dihydrogenistein,2TMS,isomer #2 | C[Si](C)(C)OC1=CC=C(C2COC3=CC(O)=CC(O[Si](C)(C)C)=C3C2=O)C=C1 | 2814.2 | Semi standard non polar | 33892256 | | Dihydrogenistein,2TMS,isomer #3 | C[Si](C)(C)OC1=CC2=C(C(=O)C(C3=CC=C(O)C=C3)CO2)C(O[Si](C)(C)C)=C1 | 2822.5 | Semi standard non polar | 33892256 | | Dihydrogenistein,3TMS,isomer #1 | C[Si](C)(C)OC1=CC=C(C2COC3=CC(O[Si](C)(C)C)=CC(O[Si](C)(C)C)=C3C2=O)C=C1 | 2783.0 | Semi standard non polar | 33892256 | | Dihydrogenistein,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC=C(C2COC3=CC(O)=CC(O)=C3C2=O)C=C1 | 3090.0 | Semi standard non polar | 33892256 | | Dihydrogenistein,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC1=CC(O)=C2C(=O)C(C3=CC=C(O)C=C3)COC2=C1 | 3060.1 | Semi standard non polar | 33892256 | | Dihydrogenistein,1TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC1=CC(O)=CC2=C1C(=O)C(C1=CC=C(O)C=C1)CO2 | 3071.2 | Semi standard non polar | 33892256 | | Dihydrogenistein,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC=C(C2COC3=CC(O[Si](C)(C)C(C)(C)C)=CC(O)=C3C2=O)C=C1 | 3293.4 | Semi standard non polar | 33892256 | | Dihydrogenistein,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC1=CC=C(C2COC3=CC(O)=CC(O[Si](C)(C)C(C)(C)C)=C3C2=O)C=C1 | 3312.2 | Semi standard non polar | 33892256 | | Dihydrogenistein,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC1=CC2=C(C(=O)C(C3=CC=C(O)C=C3)CO2)C(O[Si](C)(C)C(C)(C)C)=C1 | 3312.4 | Semi standard non polar | 33892256 | | Dihydrogenistein,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC=C(C2COC3=CC(O[Si](C)(C)C(C)(C)C)=CC(O[Si](C)(C)C(C)(C)C)=C3C2=O)C=C1 | 3468.5 | Semi standard non polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Dihydrogenistein GC-MS (Non-derivatized) - 70eV, Positive | splash10-0a4l-2790000000-26db6a2e908263b72058 | 2017-07-27 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Dihydrogenistein GC-MS (3 TMS) - 70eV, Positive | splash10-02mi-3941800000-9c483503cacf880146ba | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Dihydrogenistein GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dihydrogenistein 10V, Positive-QTOF | splash10-00di-0290000000-4644374ce6fee99f6a89 | 2015-04-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dihydrogenistein 20V, Positive-QTOF | splash10-0pi0-0970000000-1c5b97d1c0ef243d1eff | 2015-04-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dihydrogenistein 40V, Positive-QTOF | splash10-1009-6910000000-ed3a33c853a4d6d2415b | 2015-04-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dihydrogenistein 10V, Negative-QTOF | splash10-00di-0090000000-7a34d9e990680fc5c671 | 2015-04-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dihydrogenistein 20V, Negative-QTOF | splash10-00di-0290000000-811724fce8e1beb6ab95 | 2015-04-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dihydrogenistein 40V, Negative-QTOF | splash10-05mo-5920000000-87f0fb1a3e444af53d71 | 2015-04-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dihydrogenistein 10V, Positive-QTOF | splash10-00di-0090000000-031a5312b116bdf1aa4a | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dihydrogenistein 20V, Positive-QTOF | splash10-0uk9-0960000000-6d1406b5d9d548a528a5 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dihydrogenistein 40V, Positive-QTOF | splash10-0py3-9830000000-dc4e3eb841ad10a12b2e | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dihydrogenistein 10V, Negative-QTOF | splash10-00di-0090000000-d6b6f6391b4e9f4522f4 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dihydrogenistein 20V, Negative-QTOF | splash10-00di-0390000000-9cd64fafd3b06b9faac0 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dihydrogenistein 40V, Negative-QTOF | splash10-014u-6980000000-881132da1830614a043e | 2021-09-24 | Wishart Lab | View Spectrum |
|
|---|
| General References | - Chen L, Zhao X, Fang L, Games DE: Quantitative determination of acetyl glucoside isoflavones and their metabolites in human urine using combined liquid chromatography-mass spectrometry. J Chromatogr A. 2007 Jun 22;1154(1-2):103-10. Epub 2007 Mar 15. [PubMed:17499260 ]
- Hwang CS, Kwak HS, Lim HJ, Lee SH, Kang YS, Choe TB, Hur HG, Han KO: Isoflavone metabolites and their in vitro dual functions: they can act as an estrogenic agonist or antagonist depending on the estrogen concentration. J Steroid Biochem Mol Biol. 2006 Nov;101(4-5):246-53. Epub 2006 Sep 11. [PubMed:16965913 ]
|
|---|